ANASTASIA RALSTON: Open Payments
NPI 1376889071 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 39 payments from 16 companies in 2025. Trend: 2023 $347 · 2024 $383 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 10 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $142 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| ABBVIE INC. | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
Products named: SUBLOCADE, CAPLYTA, Auvelity, REXULTI, BREZTRI, FANAPT, QULIPTA, FARXIGA.
Industry payments across IN — which companies pay providers there.
